Status:

COMPLETED

The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal Volunteers

Lead Sponsor:

Seoul National University Hospital

Conditions:

Healthy

Eligibility:

All Genders

20-30 years

Phase:

PHASE4

Brief Summary

Background: * The prevalence of arthritis which needs celecoxib prescription is high in patients with coronary artery disease. * The main concern is that celecoxib would increase thrombogenicity by i...

Eligibility Criteria

Inclusion

  • healthy volunteers including both men and women 20\~30 years
  • no abnormality in physical examination, 12-lead ECG, and routine laboratory test

Exclusion

  • Subjects with cardiovascular disease, hemostatic disorder, hypersensitivity to NSAIDs and clopidogrel
  • Women with a positive pregnancy test
  • smoker
  • chronic drinkers
  • overweight exceeding 20% of standard body weight

Key Trial Info

Start Date :

March 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2005

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00882388

Start Date

March 1 2005

End Date

June 1 2005

Last Update

December 17 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seoul National University Hospital

Seoul, South Korea, 110-744